Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
34.48
+0.08 (0.23%)
Jul 23, 2026, 3:15 PM AST
TADAWUL:4017 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, TADAWUL:4017 stock has a consensus rating of "Hold" and an average price target of SAR 40.90. The average 1-year stock price forecast is 18.62% higher than the current stock price, while the lowest is SAR 38.00 (+10.21%) and the highest is SAR 44.10 (+27.90%).
Price Target: SAR 40.90 (+18.62%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4017 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Financial Forecast
Revenue This Year
3.54B
from 3.09B
Increased by 14.49%
Revenue Next Year
4.28B
from 3.54B
Increased by 20.87%
EPS This Year
1.19
from 1.26
Decreased by -5.30%
EPS Next Year
1.43
from 1.19
Increased by 19.67%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.